Detalhe da pesquisa
1.
Twelve weeks posttreatment follow-up is as relevant as 24 weeks to determine the sustained virologic response in patients with hepatitis C virus receiving pegylated interferon and ribavirin.
Hepatology
; 51(4): 1122-6, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20069649
2.
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis.
J Hepatol
; 52(5): 652-7, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20346533
3.
Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin.
Antivir Ther
; 14(4): 501-11, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19578235